DYN Dyne Therapeutics, Inc.

NEUTRAL Impact: 2/10 144
Horizon days Filed May 13, 2026 Processed 10d 5h ago SEC 0001972481-26-000156
Form 144 — notice of proposed sale of securities

Price Chart

Loading chart...

Executive Summary

Director John Cox filed a Form 144 notice of intent to sell 3,311 shares of Dyne Therapeutics common stock, valued at approximately $60,805 based on the filing date. This is a small, routine sale by a director, representing a negligible fraction of the company's $3.0B market cap, and is not indicative of material insider concern.

Actionable Insight

This is a routine, small-dollar insider sale by a director following RSU vesting. No material signal for traders. Monitor for any larger insider sales ahead of upcoming clinical catalysts or earnings.

Key Facts

  • Director John Cox filed Form 144 to sell 3,311 shares of DYN common stock.
  • Estimated sale value: ~$60,805 based on filing date.
  • Shares are from restricted stock units that vested on 05/12/2026.
  • Sale represents a tiny fraction of DYN's $3.0B market cap.
  • Recent insider activity (30d): 9 sells totaling $5.0M, indicating some ongoing insider selling but not unusual for a biotech.

Financial Impact

~$60,805 sale by a director, immaterial relative to $3.0B market cap

dilution

Risk Factors

  • Insider selling pattern may increase if more directors file 144s ahead of data readouts.
  • Biotech sector risk: any negative clinical data could amplify insider selling concerns.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001972481-26-000156
Document: 0001972481-26-000156-index.html0001972481-26-000156
Document: 0001972481-26-000156.txt0001972481-26-000156
25 reports for DYN
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+20▲ +13.90%Apr 20, 2026
Filters
Rows
Reports for DYN — sortable, filterable
Type Now
May 20, 2026
3d ago
Press Release
NEUTRAL ★ 2/10
$17.60 awaiting T+5awaiting T+5$17.37 (−1.31%)
May 20, 2026
3d ago
Press Release
BULLISH ★ 7/10
awaiting T+5
May 13, 2026
10d ago
144
NEUTRAL ★ 2/10
awaiting T+5
May 13, 2026
10d ago
144
NEUTRAL ★ 2/10
awaiting T+5
May 11, 2026
12d ago
8-K
NEUTRAL ★ 5/10
$18.46 $16.54▼ −10.40%▼ −10.32%$17.37 (−5.90%)
May 6, 2026
17d ago
144
NEUTRAL ★ 2/10
$17.54 $18.44▲ +5.13%▲ +3.63%$17.37 (−0.97%)
May 6, 2026
17d ago
144
NEUTRAL ★ 2/10
$17.54 $18.44▲ +5.13%▲ +3.63%$17.37 (−0.97%)
May 4, 2026
19d ago
144
NEUTRAL ★ 2/10
$17.47 $18.37▲ +5.15%▲ +3.17%$17.37 (−0.57%)
May 4, 2026
19d ago
144
NEUTRAL ★ 2/10
$17.47 $18.37▲ +5.15%▲ +3.17%$17.37 (−0.57%)
May 4, 2026
19d ago
144
NEUTRAL ★ 2/10
$17.47 $18.37▲ +5.15%▲ +3.17%$17.37 (−0.57%)
Showing 10 of 25

US Market Status

Market Closed — Opens Tue (34h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access